Evidence of mpox virus infection among persons without characteristic lesions or rash presenting for first dose of JYNNEOS vaccine-District of Columbia, August 2022.

Yasmin Parvizi OgaleNicolle BairdMichael B TownsendIsha BerryIsabel GriffinMichelle LeePatrick AshleyTrevor RhodesTiffany NotiganNhien WynnChantal KlingTodd SmithLalita PriyamvadaWilliam C CarsonTerese NavarraPatrick DawsonPaul J WeidleChristina WillutAnil T ManglaPanayampalli S SatheshkumarChristina L HutsonDavid A JacksonMichelle A Waltenburgnull null

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)

We assessed mpox virus prevalence in blood, pharyngeal, and rectal specimens among persons without characteristic rash presenting for JYNNEOS vaccine. Our data indicate that the utility of risk-based screening for mpox in persons without skin lesions or rash via pharyngeal swabs, rectal swabs, and/or blood is likely limited.

Keyphrases

rectal cancer
risk factors
electronic health record
big data
soft tissue
wound healing
machine learning
artificial intelligence